Endoscopic evaluation and palliation of pancreatic adenocarcinoma: Current and future options

Current Opinion in Gastroenterology

Volumn 23, Issue 5, 2007, Pages 515-521

  Pausawasdi, Nonthalee ^a   Scheiman, James ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Diagnosis; Endoscopic retrograde cholangiopancreatography; Endoscopic ultrasound; Palliation; Pancreatic adenocarcinoma

Indexed keywords

GEMCITABINE; ONYX 015;

ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; BILE DUCT OBSTRUCTION; BILIARY TRACT DRAINAGE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CELIAC PLEXUS; CHRONIC PANCREATITIS; COMPUTER ASSISTED TOMOGRAPHY; DUODENUM OBSTRUCTION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GASTROINTESTINAL ENDOSCOPY; HUMAN; INTERSTITIAL RADIATION; NEUROLYSIS; OPTICAL COHERENCE TOMOGRAPHY; PAIN; PANCREAS ADENOCARCINOMA; REVIEW;

ADENOCARCINOMA; BIOPSY, FINE-NEEDLE; BRACHYTHERAPY; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DUODENAL DISEASES; ENDOSONOGRAPHY; HUMANS; INTESTINAL OBSTRUCTION; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; PANCREATIC NEOPLASMS; STENTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34548454066     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3282ba5713     Document Type: Review

References (50)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56:106-130.
2. Duffy JP, Reber HA. Pancreatic neoplasms. Curr Opin Gastroenterol 2003; 19:458-466.
3. Abraham SC, Wilentz RE, Yeo CJ, et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all 'chronic pancreatitis'? Am J Surg Pathol 2003; 27:110-120.
4. Buscail L, Faure P, Bournet B, et al. Interventional endoscopic ultrasound in pancreatic diseases. Pancreatology 2006; 6:7-16.
5. Tessler DA, Catanzaro A, Velanovich V, et al. Predictors of cancer in patients with suspected pancreatic malignancy without a tissue diagnosis. Am J Surg 2006; 191:191-197. This study reports predictive factors for pancreatic malignancy in patients undergoing surgery for suspected pancreatic cancer without preoperative tissue diagnosis.
6. DeWitt J, Devereaux B, Chriswell M, et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer [see comment] [summary for patients in Ann Intern Med 2004; 141:I46; PMID: 15545671]. Ann Intern Med 2004; 141:753-763.
7. Dewitt J, Devereaux BM, Lehman GA, et al. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin Gastroenterol Hepatol 2006; 4:717-725. This systematic review highlights the accuracy of EUS compared with CT in preoperative assessment of patients with pancreatic malignancy.
8. Wiersema MJ. Accuracy of endoscopic ultrasound in diagnosing and staging pancreatic carcinoma. Pancreatology 2001; 1:625-632.
9. Hocke M, Schulze E, Gottschalk P, et al. Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol 2006; 12:246-250. This study highlights the ability of contrast-enhanced US to differentiate focal inflammation from pancreatic cancer.
10. Micames C, Jowell PS, White R, et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs percutaneous FNA. Gastrointest Endosc 2003; 58:690-695.
11. Paquin SC, Gariepy G, Lepanto L, et al. A first report of tumor seeding because of EUS-guided FNA of a pancreatic adenocarcinoma. Gastrointest Endosc 2005; 61:610-611.
12. Horwhat JD, Paulson EK, McGrath K, et al. A randomized comparison of EUS-guided FNA versus CT or US-guided FNA for the evaluation of pancreatic mass lesions [see comment]. Gastrointest Endosc 2006; 63:966-975. This study prospectively compared the efficacy of EUS-FNA versus CT/US-FNA. It displays the favorable role of EUS-FNA in diagnosis of pancreatic cancer.
13. Harewood GC, Wiersema MJ. A cost analysis of endoscopic ultrasound in the evaluation of pancreatic head adenocarcinoma. Am J Gastroenterol 2001; 96:2651-2656.
14. Eloubeidi MA, Tamhane A, Varadarajulu S, Wilcox CM. Frequency of major complications after EUS-guided FNA of solid pancreatic masses: a prospective evaluation. Gastrointest Endosc 2006; 63:622-629. This prospective study highlights the safety of EUS-FNA of pancreatic mass.
15. Laurell H, Bouisson M, Berthelemy P, et al. Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples. World J Gastroenterol 2006; 12:3344-3351. This study demonstrates the feasibility of gene expression analysis in EUS-FNA samples. It also displays differential expression of genes in pancreatic cancer compared with normal pancreatic tissue.
16. Tada M, Tateishi K, Kawabe T, et al. Quantity of mutant K-ras gene in pancreatic secretions for diagnosis of pancreatic carcinoma with different assays: analysis of 100 patients. Clin Chim Acta 2002; 324:105-111.
17. Itoi T, Takei K, Sofuni A, et al. Immunohistochemical analysis of p53 and MIB-1 in tissue specimens obtained from endoscopic ultrasonography- guided fine needle aspiration biopsy for the diagnosis of solid pancreatic masses. Oncol Rep 2005; 13:229-234.
18. Khalid A, Nodit L, Zahid M, et al. Endoscopic ultrasound fine needle aspirate DNA analysis to differentiate malignant and benign pancreatic masses [see comment]. Am J Gastroenterol 2006; 101:2493-2500. This study highlights the ability of DNA analysis of cytologic materials in differentiating benign from malignant pancreatic masses.
19. Mishra G, Zhao Y, Sweeney J, et al. Determination of qualitative telomerase activity as an adjunct to the diagnosis of pancreatic adenocarcinoma by EUS-guided fine-needle aspiration. Gastrointest Endosc 2006; 63:648-654. This study demonstrates that a combination of telomerase activity and cytology improves cancer detection rate.
20. Levy MJ, Topazian M, Keeney G, et al. Preoperative diagnosis of extrapancreatic neural invasion in pancreatic cancer. Clin Gastroenterol Hepatol 2006; 4:1479-1482. This report shows that EUS-FNA is able to detect tumor infiltration into celiac ganglia in patients with pancreatic cancer.
21. Chaya C, Nealon WH, Bhutani MS. EUS or percutaneous CT/US-guided FNA for suspected pancreatic cancer: when tissue is the issue. Gastrointest Endosc 2006; 63:976-978.
22. Brugge WR. Advances in the endoscopic management of patients with pancreatic and biliary malignancies. South Med J 2006; 99:1358-1366.
23. De Bellis M, Sherman S, Fogel EL, et al. Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2). Gastrointest Endosc 2002; 56:720-730.
24. De Bellis M, Sherman S, Fogel EL, et al. Tissue sampling at ERCP in suspected malignant biliary strictures (Part 1). Gastrointest Endosc 2002; 56:552-561.
25. Adamsen S, Olsen M, Jendresen MB, et al. Endobiliary brush biopsy: Intra-and interobserver variation in cytological evaluation of brushings from bile duct strictures. Scand J Gastroenterol 2006; 41:597-603. This study shows that cytological evaluation of brushing samples is generally reproducible. The observer variability occurs in difficult cases classified as atypical or suspicious.
26. Ornellas LC, Santos Gda C, Nakao FS, Ferrari AP. Comparison between endoscopic brush cytology performed before and after biliary stricture dilation for cancer detection. Arq Gastroenterol 2006; 43:20-23. This study demonstrates that a combination of brushing samples before and after dilation improved sensitivity of cytology.
27. Mansfield JC, Griffin SM, Wadehra V, Matthewson K. A prospective evaluation of cytology from biliary strictures. Gut 1997; 40:671-677.
28. Fogel EL, deBellis M, McHenry L, et al. Effectiveness of a new long cytology brush in the evaluation of malignant biliary obstruction: a prospective study [see comment]. Gastrointest Endosc 2006; 63:71-77. This study shows that the use of a larger brush increases cellular yield, but does not improve cancer detection rate.
29. Testoni PA, Mariani A, Mangiavillano B, et al. Main pancreatic duct, common bile duct and sphincter of Oddi structure visualized by optical coherence tomography: An ex vivo study compared with histology. Dig Liver Dis 2006; 38:409-414.
30. Testoni PA, Mariani A, Mangiavillano B, et al. Preliminary data on the use of intraductal optical coherence tomography during ERCP for investigating main pancreatic duct strictures. Gut 2006; 55:1680-1681. This study highlights the ability of optical coherence tomography in differentiating the neoplastic from nonneoplastic main pancreatic duct.
31. Somogyi L, Chuttani R, Croffie J, et al. Biliary and pancreatic stents. Gastrointest Endosc 2006; 63:910-919.
32. Maire F, Hammel P, Ponsot P, et al. Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas. Am J Gastroenterol 2006; 101:735-742. This study highlights the efficacy and feasibility of biliary and duodenal stent placement in palliation of patients with unresectable pancreatic cancer.
33. Lawrence C, Howell DA, Conklin DE, et al. Delayed pancreaticoduodenectomy for cancer patients with prior ERCP-placed, nonforeshortening, self-expanding metal stents: a positive outcome. Gastrointest Endosc 2006; 63:804-807. This study demonstrates positive clinical outcomes in patients who underwent SEMS placement prior to Whipple resection.
34. Prat F, Chapat O, Ducot B, et al. Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline. Gut 1998; 42:76-80.
35. Shepherd HA, Royle G, Ross AP, et al. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg 1988; 75:1166-1168.
36. Artifon EL, Sakai P, Cunha JE, et al. Surgery or endoscopy for palliation of biliary obstruction due to metastatic pancreatic cancer. Am J Gastroenterol 2006; 101:2031-2037. This study displays the favorable cost and clinical outcomes of endoscopic palliative therapy for biliary obstruction compared with surgery.
37. Yamao K, Sawaki A, Takahashi K, et al. EUS-guided choledochoduodenostomy for palliative biliary drainage in case of papillary obstruction: report of 2 cases. Gastrointest Endosc 2006; 64:663-667. This report demonstrates that EUS-guided biliary drainage can be performed in patients who failed to have biliary stent placed by ERCP.
38. Giovannini M, Moutardier V, Pesenti C, et al. Endoscopic ultrasound-guided bilioduodenal anastomosis: a new technique for biliary drainage. Endoscopy 2001; 33:898-900.
39. Burmester E, Niehaus J, Leineweber T, Huetteroth T. EUS-cholangio- drainage of the bile duct: report of 4 cases. Gastrointest Endosc 2003; 57:246-251.
40. Flamm CR, Mark DH, Aronson N. Evidence-based assessment of ERCP approaches to managing pancreaticobiliary malignancies. Gastrointest Endosc 2002; 56:S218-S225.
41. Telford JJ, Carr-Locke DL, Baron TH, et al. Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multicenter study. Gastrointest Endosc 2004; 60:916-920.
42. Maetani I, Tada T, Ukita T, et al. Comparison of duodenal stent placement with surgical gastrojejunostomy for palliation in patients with duodenal obstructions caused by pancreaticobiliary malignancies. Endoscopy 2004; 36:73-78.
43. Mittal A, Windsor J, Woodfield J, et al. Matched study of three methods for palliation of malignant pyloroduodenal obstruction. Br J Surg 2004; 91:205-209.
44. Collins D, Penman I, Mishra G, Draganov P. EUS-guided celiac block and neurolysis. Endoscopy 2006; 38:935-939.
45. Levy MJ, Wiersema MJ. EUS-guided celiac plexus neurolysis and celiac plexus block. Gastrointest Endosc 2003; 57:923-930.
46. Sun S, Xu H, Xin J, et al. Endoscopic ultrasound-guided interstitial brachytherapy of unresectable pancreatic cancer: results of a pilot trial. Endoscopy 2006; 38:399-403. This study shows that EUS-guided brachytherapy is feasible. This technique appears to have positive outcomes in patients with locally advanced pancreatic cancer.
47. Chang KJ, Nguyen PT, Thompson JA, et al. Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma. Cancer 2000; 88:1325-1335.
48. Hecht JR, Bedford R, Abbruzzese JL, et al. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res 2003; 9:555-561.
49. Chang K, Senzer N, Chung T, et al. A novel gene transfer therapy against pancreatic cancer (TNFerade) delivered by endoscopic ultrasound (EUS) and percutaneous guided fine needle injection (FNI). Gastrointest Endosc 2004; 59:AB92.
50. Farrell JJ, Senzer N, Hecht JR, et al. Long-term data for endoscopic ultrasound (EUS) and percutaneous (PTA) guided intramural TNFerade gene dilevery combined with chemoradiation in the treatment of locally advanced pancreatic cancer (LAPC). Gastrointest Endosc 2006; 63:AB93.